Because of clinical observations suggesting that nitroglycerin may suppress premature ventricular complexes during acute ischaemia, a study was undertaken to assess the effect of nitroglycerin on the incidence of premature ventricular complexes in patients with acute myocardial infarction.
An important consideration in patients with coronary artery disease, in whom the combination of premature ventricular complexes and a lowered fibrillation threshold may have lethal potential, is the need to develop reliable drugs for the treatment and prevention of ventricular arrhythmias. Numerous clinical observations provide a heuristic model for investigations into the effects of anti-ischaemic interventions on ventricular premature complexes.
For example, the occurrence of premature ventricular complexes or ventricular tachycardia during episodes of variant angina with ST segment elevation, and diminution of the ectopy with alleviation of pain and disappearance of electrocardiographic changes has been documented (Prinzmetal et al., I960) . In addition, it has been clinically observed Received 7 April 1975. 2Supported in part by the Herman C. Krannert Fund, by grants from the National Heart and Lung Institute of the National Institutes of Health, U.S. Public Health Service, and by the Indiana Heart Association. 2Research initiated during Dr. Mihalick's tenure as a U.S.P.H.S. Trainee in Cardiology.
that an increase in ventricular ectopic beats may occur during periods of probable imbalance in the supply/demand ratio for myocardial oxygenation, as with anaemia, hypoxia (Rothschild and Kissin, I933) , or heart failure (Katz and Pick, I956); treatment of these conditions may result in decreased ectopy. The occurrence of ventricular ectopic complexes coincidentally with the onset of exertional angina and the decrease in ectopy when angina diminishes (Scherf and Schott, 953; Porter, I948; Mathieu, 1927) are further evidence for a reciprocal relation between ischaemia and frequency of premature ventricular complexes. A beneficial effect of nitroglycerin on ventricular fibrillation threshold and spontaneous ventricular fibrillation during acute ischaemia in the experimental animal has been reported (Kent et al., 1974; Borer et al., I974 (Table 2) . As in the previous group, there was a significant increase in heart rate after nitroglycerin from 79 to 84 beats/ min (P < o.ooi). However, this increase occurred during the first 5 minutes after nitroglycerin. The continuous monitoring of heart rate showed that there was no significant increase in heart rate when analysed per hour. This group also showed a significant (P <o.ooi) decrease in systolic and diastolic blood pressure with nitroglycerin (i2 mmHg (I.6 kPa) systolic and 4 mmHg (o.s kPa) diastolic). As blood pressure was not continuously monitored, the duration of this effect could not be evaluated.
Discussion
The data indicate that nitroglycerin administered sublingually decreases the number of premature ventricular complexes in patients with acute myocardial infarction, and suggest that the effect may last up to 3 hours. While this is longer than is usually believed to be the therapeutic duration of sublingual nitroglycerin, this is a controversial area (Goldstein and Epstein, I973) . In addition, from our data, it is not possible to be certain exactly when recurrence of premature ventricular complexes began. The fact that the count was somewhat greater at 3 hours than at 2 hours might suggest that recurrence of ectopy began some time after 2 hours. Thus, our results are compatible with a shorter duration of nitroglycerin effect. Larger numbers of patients monitored continuously would be required to allow statistical analysis of duration of the suppressive effect of nitroglycerin.
While this study did not provide definite evidence for the mechanism of reduction of premature ventricular complexes, alleviation of ischaemia might be inferred from what is thought to be the action of nitroglycerin. In addition, nitroglycerin has been shown to decrease the extent of ischaemic area experimentally (Hirshfeld et al., I974) . Whether nitroglycerin effects primarily a reduction in myocardial oxygen demand (Bernstein et al., I966; Mason, Zelis, and Amsterdam, I97I) , increase in myocardial blood flow (Knoebel et (Gold, Leinbach, and Sanders, I972) , may cause reduction in myocardial oxygen requirement as well as improvement in subendocardial flow (Knoebel et al., I973; Becker et al., I971; Smith et al., I973) . Similar reasoning has been used to explain facilitation of defibrillation in acute ischaemia by mechanical reduction in left ventricular volume by left ventricular drainage (Kuhn et al., I972) and a decrease in premature ventricular complexes with a decreased venous return achieved by the use of lower extremity tourniquets (Knoebel and Rasmussen, I974) . Other combinations of potential nitroglycerin effects, such as decreased afterload, collateral vessel dilatation, decrease in extravascular compressive forces, etc. could be similarly invoked to explain a salutory effect on myocardial oxygen demand and supply (Becker and Pitt, I97i) and thus ischaemic area dimension. Electrophysiologically, such a reduction in ischaemic area mass might decrease the potential for sustained re-entrant activity (Han, i969; Han, Goel, and Hanson, 1970) , thought to be the mechanism for premature ventricular complexes, short bursts of ventricular tachycardia, and fibrillation (Wellens, Lie, and Durrer, I974; Han et al., 1974) . Heterogeneity of conduction and excitability (Han and Moe, I964; Hope et al., 1974) , an underlying electrophysiological condition for reentrant activity, is accentuated by ischaemia (Han, I969; Friedman, Stewart, and Wit, 1973 
